Billing and Documenting Necessity for Fluorescein Angiography on Both Eyes

Why This Topic Matters

Fluorescein angiography is a diagnostic ophthalmology service that often requires careful chart support, especially when both eyes are tested or when payer policies differ. Accurate documentation helps reduce denials, supports audits, and clarifies how unilateral versus bilateral billing is handled.

Article Sections

1. Documentation for each eye required for bilateral angiography

   Introduces the article’s focus on chart support for diagnostic eye testing when one or both eyes are involved. It frames the documentation issue in relation to billing and payer review.

2. Billing and documentation considerations

   Discusses general billing concerns for bilateral testing, including how payer type can affect claim submission and documentation expectations. It also addresses chart elements used to support medical necessity.

3. Carrier guidance and frequency considerations

   Summarizes payer-specific commentary about diagnostic testing frequency and review practices. This section highlights that carrier policies may affect how often the service is expected to occur.

4. Modifier use and claim presentation

   Covers how claims for the service may be formatted and the role of side-specific or bilateral claim reporting. It also notes that payer handling may differ between diagnostic and commercial claims.

5. What to look for in supporting notes

   Describes the general types of documentation reviewers expect to find in the record. It emphasizes the need for clear clinical support within the ophthalmology note.

6. Private payer caution

   Notes that commercial payers may interpret ophthalmic diagnostic testing differently from Medicare. This section warns that coverage and payment outcomes may vary.